Find Federal Grants

Status

Agency

NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

★ Save Posted

National Institutes of Health · PAR-25-141

Closes: Mar 4, 2027

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

★ Save Posted

National Institutes of Health · PAR-24-280

Closes: Nov 2, 2026

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)

★ Save Posted

National Institutes of Health · PAR-24-279

Closes: Nov 2, 2026

Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)

★ Save Posted

National Institutes of Health · PAR-25-100

Closes: May 7, 2027

Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)

★ Save Posted

National Institutes of Health · PAR-24-330

Closes: Sep 7, 2027

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

★ Save Posted

National Institutes of Health · RFA-TR-25-002

Closes: Jul 2, 2027

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)

★ Save Posted

National Institutes of Health · PAR-25-298

Closes: Jan 7, 2028 Up to: $375,000

Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)

★ Save Posted

National Institutes of Health · PAR-25-299

Closes: Jan 7, 2028

Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

★ Save Posted

National Institutes of Health · RFA-DA-26-056

Closes: Dec 3, 2027

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

★ Save Posted

National Institutes of Health · RFA-DA-26-055

Closes: Dec 3, 2027

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

★ Save Posted

National Institutes of Health · PAR-25-026

Closes: Jan 7, 2027

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

★ Save Posted

National Institutes of Health · PAR-25-025

Closes: Jan 7, 2027 Up to: $1,515,000

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

★ Save Posted

National Institutes of Health · PAR-25-297

Closes: Nov 5, 2027 Up to: $1,500,000

Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)

★ Save Posted

National Institutes of Health · PAR-25-310

Closes: Jan 7, 2027

NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)

★ Save Posted

National Institutes of Health · PAR-25-251

Closes: Jan 7, 2028 Up to: $150,000 Program funding: $150,000

NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)

★ Save Posted

National Institutes of Health · PAR-25-271

Closes: Nov 13, 2026 Program funding: $350,000

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

★ Save Posted

National Institutes of Health · PAR-25-270

Closes: Nov 13, 2026 Up to: $1,050,000 Program funding: $1,050,000

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

★ Save Posted

National Institutes of Health · PAR-25-269

Closes: Nov 13, 2026 Up to: $350,000 Program funding: $350,000

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)

★ Save Posted

National Institutes of Health · PAR-25-266

Closes: Nov 16, 2027 Up to: $200,000 Program funding: $200,000

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

★ Save Posted

National Institutes of Health · PAR-25-265

Closes: Nov 16, 2027